130 related articles for article (PubMed ID: 35771689)
21. Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction.
Buragohain P; Saikia B; Surineni N; Barua NC; Saxena AK; Suri N
Bioorg Med Chem Lett; 2014 Jan; 24(1):237-9. PubMed ID: 24332623
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents.
Xu Z; Pan B; Chen L; Xu D
Fitoterapia; 2023 Apr; 166():105436. PubMed ID: 36693438
[TBL] [Abstract][Full Text] [Related]
23. Artemisinin-derived hybrids and their anticancer activity.
Gao F; Sun Z; Kong F; Xiao J
Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
Gerard Y; Voissière A; Peyrode C; Galmier MJ; Maubert E; Ghedira D; Tarrit S; Gaumet V; Canitrot D; Miot-Noirault E; Chezal JM; Weber V
Bioorg Chem; 2020 May; 98():103747. PubMed ID: 32208207
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological activities of novel mitochondria-targeted artemisinin ester derivatives.
Xu C; Xiao L; Zhang X; Zhuang T; Mu L; Yang X
Bioorg Med Chem Lett; 2021 May; 39():127912. PubMed ID: 33691167
[TBL] [Abstract][Full Text] [Related]
26. Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
Li X; Zhou Y; Liu Y; Zhang X; Chen T; Chen K; Ba Q; Li J; Liu H; Wang H
EBioMedicine; 2016 Dec; 14():44-54. PubMed ID: 27939426
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach.
Xie L; Zhai X; Ren L; Meng H; Liu C; Zhu W; Zhao Y
Chem Pharm Bull (Tokyo); 2011; 59(8):984-90. PubMed ID: 21804243
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells.
Letis AS; Seo EJ; Nikolaropoulos SS; Efferth T; Giannis A; Fousteris MA
Bioorg Med Chem; 2017 Jul; 25(13):3357-3367. PubMed ID: 28456567
[TBL] [Abstract][Full Text] [Related]
29. Novel N-mustard-benzimidazoles/benzothiazoles Hybrids, Synthesis and Anticancer Evaluation.
Detroja D; Chen TL; Lin YW; Yen TY; Wu MH; Tsai TH; Mehariya K; Kakadiya R; Lee TC; Shah A; Su TL
Anticancer Agents Med Chem; 2017; 17(13):1741-1755. PubMed ID: 28530540
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen.
Wu X; Hu L
Bioorg Med Chem; 2016 Jun; 24(12):2697-706. PubMed ID: 27156193
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anticancer activity of novel deoxoartemisinin-glycolipid hybrids.
Min D; Kim M; Ricci J; Jung S; Kim K; Chung WY; Park KK; Jung M
Chem Pharm Bull (Tokyo); 2014; 62(5):446-53. PubMed ID: 24614158
[TBL] [Abstract][Full Text] [Related]
32. Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities.
An R; Lin B; Zhao S; Cao C; Wang Y; Cheng X; Liu Y; Guo M; Xu H; Wang Y; Hou Z; Guo C
Bioorg Chem; 2020 Nov; 104():104347. PubMed ID: 33142414
[TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis, and Antitumor Activities of Isomers of Artemisinin Dimer Derivatives.
Yue L; Pan Y; Wang J; Yue L; Luo Y; Lv F; Lv J; Chen J; Zhao Q; Lin H
Chem Biodivers; 2023 Jul; 20(7):e202300615. PubMed ID: 37256824
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity.
Gaur R; Pathania AS; Malik FA; Bhakuni RS; Verma RK
Eur J Med Chem; 2016 Oct; 122():232-246. PubMed ID: 27371926
[TBL] [Abstract][Full Text] [Related]
35. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
Jain M; Fan J; Baturay NZ; Kwon CH
J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo.
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2019 Nov; 182():111665. PubMed ID: 31494469
[TBL] [Abstract][Full Text] [Related]
37. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
Kwon CH; Moon KY; Baturay N; Shirota FN
J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and cytotoxicity evaluation of naphthalimide derived N-mustards.
Lou Q; Ji L; Zhong W; Li S; Yu S; Li Z; Meng X
Molecules; 2014 Jun; 19(7):8803-19. PubMed ID: 24968335
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of cytotoxic activities of artemisinin derivatives.
Sun Q; Wang J; Li Y; Zhuang J; Zhang Q; Sun X; Sun D
Chem Biol Drug Des; 2017 Nov; 90(5):1019-1028. PubMed ID: 28489280
[TBL] [Abstract][Full Text] [Related]
40. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities.
Liu G; Song S; Shu S; Miao Z; Zhang A; Ding C
Eur J Med Chem; 2015 Oct; 103():17-28. PubMed ID: 26318055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
